Restless Leg Syndrome
Opioids may be "life-transforming" for patients with refractory restless legs syndrome when taken in relatively low total daily doses, according to new guidelines.
The dopaminergic medication rotigotine and the α-2-δ ligands gabapentin enacarbil and pregabalin provide similar treatment effects for patients with restless leg syndrome.
Nerve decompression used to treat peripheral neuropathy may improve symptoms of restless leg syndrome.
Acute migraine attacks are associated with a reduction in dopamine release.
In the new guidelines, the authors aimed to examine the available data to clarify which pharmacologic and non-pharmacologic treatments are safe and effective for RLS.
Clinical Pain Advisor Articles
- Trigger Point Injections, Pulsed Radiofrequency for Abdominal Myofascial Pain Syndrome
- Safety, Efficacy of Lidocaine Infusion for Prolonged Neuropathic Pain
- Assessing the Efficacy of Low-Dose Amitriptyline for Idiopathic Chronic Neck Pain
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Trigger Point Dry Needling Plus Exercise Cost-Effective for Subacromial Pain Syndrome
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Spinal Manipulative Therapy May Effectively Reduce Cervicogenic Headache Days
- Chronic Pain in Adolescents and Alexithymia
- Bedside Quantitative Sensory Testing May Reliably Assess Sensory Profiles in Neuropathic Pain
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- The Link Between Medical Malpractice and Defensive Medicine
- Drug Copayments Often Exceed Prescription Drug Costs